LifeClean International (LCLEAN) Q2 2024 earnings summary

Executive summary

• Net sales rose 46% year-over-year to 20.9 MSEK in Q2 2024, driven by growth in key business areas.

• Increased costs related to regulatory applications and product development impacted profitability.

• Significant orders and recurring business in PFAS decontamination and agriculture segments strengthened market position.

• A directed share issue post-period raised 32.25 MSEK to support ongoing projects and expansion.

Financial highlights

• Q2 net sales: 20,931 TSEK (14,301), H1: 36,788 TSEK (27,960).

• Adjusted EBITDA Q2: -6,586 TSEK (-3,438); EBITDA: -9,316 TSEK (-7,605); EBIT: -11,603 TSEK (-9,817).

• H1 adjusted EBITDA: -13,883 TSEK (-5,934); EBIT: -25,500 TSEK (-16,722).

• Cash flow from operations Q2: -8,182 TSEK (-10,405); H1: -22,611 TSEK (-19,888).

• Cash at period end: 3,405 TSEK (24,858); equity: -8,085 TSEK (25,773); net debt: 45,454 TSEK (22,306).

Outlook and guidance

• Long-term partnership with Presto Group expected to generate 10 MSEK annual orders in Sweden.

• Raised capital to be used for project deliveries and business volume growth across all segments.

• Focus on regulatory approvals and market expansion to drive future growth.